Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Magnesium Research|June 1, 1997
Voltage dependence of the pharmacological Mg2+ block of the Ca2+ entry into vascular smooth muscle cellsG Fleckenstein-Grün, S Matyas, L DumontFortschritte Der Medizin|July 26, 1984
[Possibilities in the future application of calcium antagonists. Is the prevention of blood vessel calcinosis possible?]A Fleckenstein, M Frey, G Fleckenstein-GrünJournal of Cardiovascular Pharmacology|May 5, 1999
Extracellular ATP increases [Ca2+]i in primarily cultured pig coronary smooth muscle cells via a P2Y purinoceptor subtypeL Seiler, S Matyas, G Fleckenstein-GrünEuropean Heart Journal|December 1, 1983
Consequences of uncontrolled calcium entry and its prevention with calcium antagonistsA Fleckenstein, M Frey, G Fleckenstein-GrünAngiology|August 1, 1989
Free calcium in rat papillary muscle at contraction assessed with Ca-selective microelectrodesR Gasser, M Frey, G Fleckenstein-GrünThe American Journal of Cardiology|February 26, 1986
Antihypertensive and arterial anticalcinotic effects of calcium antagonistsA Fleckenstein, M Frey, G Fleckenstein-GrünZeitschrift Fur Geburtshilfe Und Neonatologie|February 24, 1999
[Acute fatty liver of pregnancy (AFLP) as a rare and severecomplication and differential diagnostic problem in the last trimester]G Fleckenstein, B Eppmann, M Mengringhaus, et al.The American Journal of Cardiology|November 7, 1989
Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profileA Fleckenstein, M Frey, J Zorn, et al.Journal of Human Hypertension|December 1, 1992
Protective effects of various calcium antagonists against experimental arteriosclerosisG Fleckenstein-Grün, M Frey, F Thimm, et al.The American Journal of Cardiology|December 6, 1985
Experimental basis of the long-term therapy of arterial hypertension with calcium antagonistsA Fleckenstein, M Frey, J Zorn, et al.Pageof 4